6:26 pm - Monday December 18, 2017

Mixing right cocktail of proteins can help build better malaria vaccine

135 Viewed News Editor Comments Off on Mixing right cocktail of proteins can help build better malaria vaccine
Mixing right cocktail of proteins can help build better malaria vaccine
Mixing right cocktail of proteins can help build better malaria vaccine

Washington – Researchers including an Indian-origin scientist have suggested that that a cocktail of AMA1 proteins from only a few different strains can overcome major limitations of an earlier designed version of AMA1-based malaria vaccines.

A team led by led by Sheetij Dutta, from the Walter Reed Army Institute of Research, USA, focused on a protein called AMA1 needed by the Plasmodium falciparum parasite to invade blood cells and cause disease.

The challenge with the malaria parasite in general and its AMA1 surface protein in particular is that both exist as multiple strains. Using AMA1 in a vaccine readies the human immune system for subsequent encounters with the parasite, but when such a vaccine was previously tested in humans, it was effective mostly against one particular P. falciparum strain.

To explore the potential for a more broadly protective vaccine, the scientists tested different cocktails of AMA1 from different parasite strains for their ability to elicit a diverse range of antibodies that are active in parasite inhibition assays.

They confirmed that a cocktail of AMA1 proteins from three different parasite strains was better than one or two, and one they call Quadvax, which contained AMA1 proteins derived from four different strains, led to an antibody response that was broader than the sum of strain-specific antibodies elicited by the four individual strains.

Moreover, Quadvax-elicited antibodies inhibited a range of parasites, including many strains that were different from those in the Quadvax mix. In different laboratory tests, Quadvax-induced antibodies inhibited the growth of 26 different parasite strains, and the scientists suggest that “the combination of four AMA1 variants in Quadvax may be sufficient to overcome global AMA1 diversity”.

The study is published in journal PLOS Pathogens.

Don't miss the stories followIndiaVision News & Information and let's be smart!
Loading...
0/5 - 0
You need login to vote.
Filed in
NASA and Japan’s space agency announce launch date for global precipitation satellite

NASA and Japan’s space agency announce launch date for global precipitation satellite

2013: year of maximum Internet IPOs since 2000

UN human rights chief says Internet privacy as important as human rights

Related posts